Business Context and Reporting Period
Company: Chicago Atlantic BDC, Inc. (formerly Silver Spike Investment Corp.)
Reporting Period: Fiscal Year Ended December 31, 2024
Structure: Externally managed, closed-end, non-diversified Business Development Company (BDC) and Regulated Investment Company (RIC).
Strategy: Specialty finance focused on the cannabis ecosystem and lower middle-market companies. In April 2024, the strategy expanded to include growth/technology, esoteric asset-based lending, and liquidity solutions outside the cannabis sector.
Key Event: On October 1, 2024, the Company completed a Loan Portfolio Acquisition from Chicago Atlantic Loan Portfolio, LLC (CALP), issuing 16.6 million shares in exchange for a loan portfolio valued at approximately $219.6 million. This transaction significantly increased the Company's asset base and share count.
Key Financial Metrics
| Metric | 2024 | 2023 |
|---|---|---|
| Total Investment Portfolio (Fair Value) | $275.2 million | $54.1 million |
| Total Investment Income | $21.7 million | $11.9 million |
| Net Investment Income | $9.5 million | $6.6 million |
| Net Realized Gain/(Loss) | ($0.1 million) | ($0.2 million) |
| Net Change in Unrealized Appreciation | $0.2 million | $0.9 million |
| Total Operating Expenses | $12.2 million | $5.3 million |
| Cash and Cash Equivalents | $23.9 million | $32.6 million |
| Net Assets | $301.2 million | $85.6 million |
| Net Asset Value (NAV) per Share | $13.20 | $13.77 |
| Shares Outstanding | 22.8 million | 6.2 million |
Expense Breakdown (2024): Transaction expenses related to the Loan Portfolio Acquisition were $5.3 million. Income-based incentive fees were $2.3 million, and the base management fee was $1.5 million.
Material Changes vs. Prior Period
- Portfolio Expansion: The investment portfolio grew by approximately $221 million (409%) primarily due to the Loan Portfolio Acquisition. The portfolio composition shifted from 100% cannabis in 2023 to 76.7% cannabis, 11.2% finance/insurance, and other sectors in 2024.
- Revenue Growth: Total investment income increased 82% year-over-year, driven by the larger principal balance of debt investments ($277 million in 2024 vs. $55 million in 2023).
- Expense Surge: Total operating expenses increased 130% to $12.2 million, largely attributable to $5.3 million in transaction costs associated with the Loan Portfolio Acquisition.
- Share Count: Outstanding shares increased from 6.2 million to 22.8 million due to the issuance of shares to CALP in the acquisition.
- Stock Performance: As of March 28, 2025, the stock traded at $11.44, representing a 13.3% discount to the December 31, 2024 NAV of $13.20.
Guidance, Outlook, and Risks
Management Commentary & Outlook:
- Investment Pipeline: The Company is currently reviewing approximately $644 million of potential investments.
- Expense Cap: An Expense Limitation Agreement caps operating expenses (excluding management fees, incentive fees, acquisition expenses, and litigation) at 2.15% of net assets through September 30, 2025. A clarification in February 2025 excluded debt/equity raising costs from this cap.
- Liquidity: On February 11, 2025, the Company entered into a $100 million senior secured revolving credit facility with Western Alliance Bank, maturing in March 2028.
- Distributions: The Company declared a quarterly dividend of $0.34 per share on March 13, 2025, payable April 11, 2025.
Risks and Contingencies:
- Cannabis Regulatory Risk: Cannabis remains illegal under U.S. federal law. Strict enforcement could impair portfolio companies' ability to operate. Rescheduling efforts have stalled, creating uncertainty regarding tax relief (Section 280E) and banking access.
- Concentration Risk: As of December 31, 2024, the top three portfolio companies represented 45.1% of the portfolio's fair value.
- Valuation Uncertainty: 100% of the portfolio is classified as Level 3 assets, requiring significant management judgment and unobservable inputs for fair value determination.
- Shareholder Dilution/Sales: CALP and the Adviser collectively hold approximately 80% of voting stock. CALP intends to distribute shares to its members within six months of the acquisition, which could increase selling pressure.
Key Facts for Investor Verification
- Acquisition Integration: Verify the performance of the $219.6 million loan portfolio acquired in October 2024 and whether it is generating expected yields.
- Expense Cap Compliance: Monitor if the Company remains within the 2.15% expense cap (excluding specific items) and the impact of the new $100 million credit facility on future interest expenses.
- Dividend Sustainability: Assess whether Net Investment Income ($9.5M) is sufficient to cover the quarterly dividend rate of $0.34/share ($7.76M annualized) without relying on return of capital or borrowings.
- Regulatory Environment: Track developments in U.S. federal cannabis policy (rescheduling, SAFE Banking Act) which directly impacts the creditworthiness of the 76.7% of the portfolio invested in cannabis.
- Shareholder Structure: Monitor the potential sale of shares by CALP members, which could impact the stock price and the Company's ability to raise equity capital.